1. |
Chen W. Cancer statistics: updated cancer burden in China. Chin J Cancer Res, 2015, 27(1): 1.
|
2. |
Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin, 2011, 61(2): 69-90.
|
3. |
中华人民共和国国家卫生和计划生育委员会. 原发性肝癌诊疗规范 (2017 年版). 传染病信息, 2017, 16(3): 705-720.
|
4. |
Dimitroulis D, Damaskos C, Valsami S, et al. From diagnosis to treatment of hepatocellular carcinoma: An epidemic problem for both developed and developing world. World J Gastroenterol, 2017, 23(29): 5282-5294.
|
5. |
Bruix J, Hessheimer AJ, Forner A, et al. New aspects of diagnosis and therapy of hepatocellular carcinoma. Oncogene, 2006, 25(27): 3848-3856.
|
6. |
Aravalli RN, Steer CJ, Cressman EN. Molecular mechanisms of hepatocellular carcinoma. Hepatology, 2008, 48(6): 2047-2063.
|
7. |
Zinkin NT, Grall F, Bhaskar K, et al. Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease. Clin Cancer Res, 2008, 14(2): 470-477.
|
8. |
Wu Y, Yu J, Ma Y, et al. miR-148a and miR-375 may serve as predictive biomarkers for early diagnosis of laryngeal carcinoma. Oncol Lett, 2016, 12(2): 871-878.
|
9. |
Lin H, Ewing LE, Koturbash I, et al. MicroRNAs as biomarkers for liver injury: Current knowledge, challenges and future prospects. Food Chem Toxicol, 2017, 110: 229-239.
|
10. |
Armand-Labit V, Pradines A. Circulating cell-free microRNAs as clinical cancer biomarkers. Biomol Concepts, 2017, 8(2): 61-81.
|
11. |
Fu Y, Wei X, Tang C, et al. Circulating microRNA-101 as a potential biomarker for hepatitis B virus-related hepatocellular carcinoma. Oncol Lett, 2013, 6(6): 1811-1815.
|
12. |
於琳, 张开炯, 柴利, 等. 原发性肝癌患者癌组织、血清 miR-202 表达变化及其意义. 山东医药, 2017, 57(7): 1-4.
|
13. |
Armengol C, Sarrias MR, Sala M. Hepatocellular carcinoma: Present and future. Med Clin (Barc), 2017 Oct 30. pii: S0025-7753(17)30717-0. doi: 10.1016/j.medcli.2017.08.010. [Epub ahead of print].
|
14. |
Siddique O, Yoo ER, Perumpail RB, et al. The importance of a multidisciplinary approach to hepatocellular carcinoma. J Multidiscip Healthc, 2017, 10: 95-100.
|
15. |
Huang Z, Huang D, Ni S, et al. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer, 2010, 127(1): 118-126.
|
16. |
Hu Z, Chen X, Zhao Y, et al. Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer. J Clin Oncol, 2010, 28(10): 1721-1726.
|
17. |
Liu AM, Yao TJ, Wang W, et al. Circulating miR-15b and miR-130b in serum as potential markers for detecting hepatocellular carcinoma: a retrospective cohort study. BMJ Open, 2012, 2(2): e000825.
|
18. |
Fiorino S, Bacchi-Reggiani ML, Visani M, et al. MicroRNAs as possible biomarkers for diagnosis and prognosis of hepatitis B- and C-related-hepatocellular-carcinoma. World J Gastroenterol, 2016, 22(15): 3907-3936.
|
19. |
孟凡龙, 荚卫东, 许戈良, 等. 肝癌患者血清 miR-106 b 的表达变化及其临床意义. 安徽医科大学学报, 2014, 49(3): 334-337, 338.
|
20. |
Xu J, Wu C, Che X, et al. Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis. Mol Carcinog, 2011, 50(2): 136-142.
|
21. |
Zhang Y, Jia Y, Zheng R, et al. Plasma microRNA-122 as a biomarker for viral-, alcohol-, and chemical-related hepatic diseases. Clin Chem, 2010, 56(12): 1830-1838.
|
22. |
Gui J, Tian Y, Wen X, et al. Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies. Clin Sci (Lond), 2011, 120(5): 183-193.
|
23. |
Qu KZ, Zhang K, Li H, et al. Circulating microRNAs as biomarkers for hepatocellular carcinoma. J Clin Gastroenterol, 2011, 45(4): 355-360.
|
24. |
Shen S, Lin Y, Yuan X, et al. Biomarker micrornas for diagnosis, prognosis and treatment of hepatocellular carcinoma: a functional survey and comparison. Sci Rep, 2016, 6: 38311.
|
25. |
Meyer-Rochow GY, Jackson NE, Conaglen JV, et al. MicroRNA profiling of benign and malignant pheochromocytomas identifies novel diagnostic and therapeutic targets. Endocr Relat Cancer, 2010, 17(3): 835-846.
|
26. |
李迎迎, 王森嵩. MiR-483-5p 在食管鳞癌血清和组织中的表达及其调控机理的初步探究. 河南师范大学, 2016.
|
27. |
Patterson EE, Holloway AK, Weng J, et al. MicroRNA profiling of adrenocortical tumors reveals miR-483 as a marker of malignancy. Cancer, 2011, 117(8): 1630-1639.
|
28. |
Yao M, Zhao J, Lu F. Alpha-fetoprotein still is a valuable diagnostic and prognosis predicting biomarker in hepatitis B virus infection-related hepatocellular carcinoma. Oncotarget. 2016; 7(4): 3702-3708.
|